Immunovaccine develops vaccines for cancer immunotherapies and infectious diseases.
Business Model:
Revenue: $199.2k
Employees: 11-50
Address: 1344 Summer Street
City: Halifax
State: nova scotia
Zip: B3H 0A8
Country: CA
Immunovaccine develops vaccines for cancer immunotherapies and infectious diseases.
Contact Phone:
+19024921819
Contact Email:
Listed Exchange:
TMX Group - Toronto Stock Exchange
IPO Date:
11/2/2007
Ticker Symbol:
IMV
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2017 | Post-IPO Equity | $7.4M | 12/2021 | Post-IPO Debt | 1 | $25M |
Horizon Technology Finance Horizon Technology Finance |
9/2014 | Post-IPO Equity | $10.3M | 5/2020 | Post-IPO Equity | 3 | $18M |
Lumira Ventures Fonds de solidarité FTQ Altium Capital Lumira Ventures Fonds de solidarité FTQ Altium Capital |
11/2013 | Post-IPO Equity | $4.2M | 1/2006 | Private Equity Round | 1 | - |
Brigus Capital Brigus Capital |
6/2016 | Post-IPO Equity | 1 | $6.3M |
CTI Life Sciences Fund CTI Life Sciences Fund |
5/2016 | Equity | $8M | 1/2006 | Private Equity Round | 1 | - |
Brigus Capital Brigus Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|